Immunohistochemistry of tumour tissues has previously found moderate or strong ERBB3 expression in 11–49% (Rajkumar et al, 1996; Chow et al, 1997, 2001; Rotterud et al, 2005). The gene discussed is ERBB3; the disease is neoplasm.